Medherant said today that it successfully finished two Phase I studies with its ibuprofen transdermal drug-delivery patch.
According to the UK-based company, the Tepi patch was well tolerated by the participants of a skin irritation study.
Get the full story at our sister site, Drug Delivery Business News.
The post Medherant touts results for ibuprofen transdermal patch appeared first on MassDevice.
from MassDevice https://ift.tt/2SMSdpZ
Cap comentari:
Publica un comentari a l'entrada